LIVE GMP
🔥 Kwick Forensic: Listed @190 (+86.67%)
Lumino Industries: Listed @110 (+46.34%)
🌟 Rays of Belief: GMP +₹13 (Closes Today)
💍 Deepa Jewellers: GMP +₹18 (Closes Today)
🚀 Kanohar Electricals: GMP +₹140 (22.15%)
📈 Qualiance Intl: GMP +₹55 (43.31%)
🔥 Kwick Forensic: Listed @190 (+86.67%)
Lumino Industries: Listed @110 (+46.34%)
🌟 Rays of Belief: GMP +₹13 (Closes Today)
💍 Deepa Jewellers: GMP +₹18 (Closes Today)
🚀 Kanohar Electricals: GMP +₹140 (22.15%)
📈 Qualiance Intl: GMP +₹55 (43.31%)

ABH Healthcare

ABH Healthcare IPO Date, Review, Price, Allotment Details

ABH Healthcare IPO open date is August 24, 2026 and the IPO will close on August 27, 2026. ABH Healthcare IPO is a Book built Issue. The company to raise around ₹34.98 crores via IPO that comprises fresh issue of ₹34.98 crores and offer for sale up to [.] equity shares with face value of ₹10 each.

ABH Healthcare IPO price band is ₹96 to ₹102 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. ABH Healthcare IPO to list on NSE SME on September 1, 2026. The allotment of ABH Healthcare IPO date is August 28, 2026.

The company reported revenue of ₹52.59 crores in 2026 against ₹49.32 crores in 2025. The company reported profit of ₹5.64 crores in 2026 against profit of ₹5.35 crores in 2025. As per the financials, the IPO investors should apply the IPO for a long term.

ABH Healthcare IPO Details

IPO Open Date August 24, 2026
IPO Close Date August 27, 2026
Face Value ₹10 Per Equity Share
IPO Price Band ₹96 to ₹102 Per Share
Issue Size Approx ₹34.98 Crores
Fresh Issue Approx ₹34.98 Crores
Issue Type Book Building Issue
IPO Listing NSE SME
DRHP Draft Prospectus PDF
RHP Draft Prospectus PDF
ABH Healthcare IPO Market Lot

The ABH Healthcare IPO minimum market lot is 2,400 shares with ₹2,44,800 application amount.

Application Lot Size Shares Amount
Retail Minimum 2 2,400 ₹2,44,800
Retail Maximum 2 2,400 ₹2,44,800
S-HNI Minimum 3 3,600 ₹3,67,200
S-HNI Maximum 8 9,600 ₹9,79,200
B-HNI Minimum 9 10,800 ₹11,01,600

IPO Reservation

Investor Category Share Offered -% Shares
Anchor Investor – Shares -%
QIB (Ex. Anchor) 1,99,200 Shares 10.49%
NII Shares Offered 1,70,600 Shares 8.99%
Retail Shares Offered 15,28,800 Shares 80.52%

ABH Healthcare IPO Dates

The ABH Healthcare IPO date is August 24 and the close date is August 26. The ABH Healthcare IPO allotment will be finalized on August 27 and the IPO listing on August 31.

IPO Open Date: August 24, 2026
IPO Close Date: August 27, 2026
Basis of Allotment: August 28, 2026
Refunds: August 31, 2026
Credit to Demat Account: August 31, 2026
IPO Listing Date: September 1, 2026

Promoters and Holding Pattern

The promoters of the company are Kamal Baghi, Saurabh Baghi and Vaishali Saini.

Particular Pre IPO Shares Pre IPO % Shares Post IPO Shares Post IPO % Shares
Promoter and Promoter Group 79,99,996 100% -%
Others* 4 0% -%
Total 80,00,000  100% 1,14,29,600 100%

Objects of the Issue & Utilisation of Proceeds

Purpose Crores
Repayment / prepayment, in part or full, of certain of our borrowings ₹17.00
Funding our Working Capital Requirements; and ₹4.30
Funding inorganic growth through unidentified acquisitions and general corporate purposes (collectively referred to as “Objects”) ₹-

About ABH Healthcare IPO

ABH Healthcare, which operates under the brand “Anil Baghi Hospital,” is a healthcare service provider. It is a multi-speciality hospital brand that provides 25 medical specialties: cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc.

ABH Healthcare offers healthcare services under various government healthcare schemes and organisations, including ECHS, Indian Railways, FCI, BSNL, and Ayushman Bharat–Sarbat Sehat Bima Yojana (ABSSBY). As of FY25, the firm includes 29 doctors and 137 nurses. Its competitive strengths are a professional management team, providing quality clinical care, modern equipment, and a track record of stable financial growth.

Company Financials

Amount ₹ in Crores

Period Ended Revenue Expense PAT Assets
2024 ₹41.39 ₹39.19 ₹1.66 ₹51.35
2025 ₹49.32 ₹41.89 ₹5.35 ₹63.90
2026 ₹52.59 ₹44.66 ₹5.64 ₹85.27

Company Valuation – FY2026

Check ABH Healthcare IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

KPI Values
ROE: 39.07%
ROCE: 19.09%
EBITDA Margin: 28.03%
PAT Margin: 10.74%
Debt to equity ratio: 3.20
Earning Per Share (EPS): ₹7.05 (Basic)
Price/Earning P/E Ratio: N/A
Return on Net Worth (RoNW): 39.07%
Net Asset Value (NAV): ₹21.58

Peer Group Comparison

Company EPS PE Ratio RoNW % NAV Income
Sangani Hospitals Limited 2.17 24.52 16.20% 23.30 106.96 Cr.
Maitreya Medicare Limited (3.64) (34.11) (8.10)% 42.67 44.85 Cr.
Asarfi Hospital Limited 8.47 27.63 18.65% 49.62 173.50 Cr.

IPO Lead Managers aka Merchant Bankers

  • Fedex Securities Pvt.Ltd.

Company Address

ABH Healthcare Ltd.
Anil Baghi Road, Ferozepur,
Punjab
Firozpur, Punjab, 152002
Phone: +91 7888690018
Email: investor@anilbaghihospital.com
Website: https://www.abhhealthcare.org/

IPO Registrar

Bigshare Services Pvt. Ltd.
Phone: 8657578989/8069219065/8069219060
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html

ABH Healthcare IPO FAQs

What is ABH Healthcare IPO?

ABH Healthcare IPO is Mainboard IPO. The company is going to raise ₹34.98 Crores via IPO. The issue is priced at ₹96 to ₹102 per equity share. The IPO is to be listed on NSE SME.

When ABH Healthcare IPO will open for subscription?

The IPO is to open on August 24, 2026 for QIB, NII, and Retail Investors. The IPO will close on August 27, 2026.

What is ABH Healthcare IPO Investors Portion?

The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.

How to Apply the ABH Healthcare IPO?

You can apply for ABH Healthcare IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

What is ABH Healthcare IPO Issue Size?

ABH Healthcare IPO issue size is ₹34.98 crores.

What is ABH Healthcare IPO Price Band?

ABH Healthcare IPO Price Band is ₹96 to ₹102.

What is ABH Healthcare IPO Lot Size?

The minimum bid is 2400 Shares with ₹2,44,800 amount.

What is the ABH Healthcare IPO Allotment Date?

ABH Healthcare IPO allotment date is August 28, 2026.

What is the ABH Healthcare IPO Listing Date?

ABH Healthcare IPO listing date is September 1, 2026. The IPO is to list on NSE SME.

Note: The ABH Healthcare IPO price band and date are officially announced. The (ABH Healthcare IPO grey market premium) will be added to the IPO GMP page as it will start)

ABH Healthcare IPO Review (NSE SME) – Well-informed/cash surplus/risk seekers may park moderate funds for long term

Sector
Healthcare
IPO Open
Aug 24, 2026
IPO Close
Aug 27, 2026
IPO Size
₹34.98 Crore

Based on upper price band

Price Band
₹96 to ₹102

per equity share

Minimum Lot
2,400 Shares

In multiple of 1,200 shares

  • The company is engaged in the business of providing healthcare services in Tier-3 cities in the northern region.
  • It has a capacity of 150 beds and empaneled with private and public health insurance companies.
  • The company posted growth in its top and bottom lines, with affordable health related services.
  • It is operating in a highly competitive and fragmented segment.
  • Based on its recent financial data, the issue appears fully priced.
  • Well-informed/cash surplus/risk seekers may park moderate funds for long term.

Issue Details / Capital History

The company is coming out with its maiden book building route IPO of 3429600 equity shares of Rs. 10 each to mobilize Rs 34.98 cr. at the upper cap. The company has announced a price band of Rs. 96 – Rs. 102 per share. The minimum application to be made is for 2400 shares and in multiples of 1200 shares thereon, thereafter. The IPO opens for subscription on August 24, 2026, and will close on August 27, 2026. The IPO constitute 30.01% of the post-IPO paid-up capital of the company. The shares will be listed on NSE SME Emerge. From the net proceeds of the fresh equity issue, it will utilize Rs. 5.00 cr. for working capital, Rs. 17.00 cr. for repayment/prepayment of certain borrowings, and the rest for general corporate purposes.

The IPO is solely lead managed by Fedex Securities Pvt. Ltd., while Bigshare Services Pvt. Ltd., is the registrar to the issue. Rikhav Securities Ltd., is the market and also a syndicate member.

After issuing initial equity capital at par value, the company issued further equity shares at a fixed price of Rs. 20 per share in November 2022. It also issued bonus shares in the ratio of 3 for 1 in August 2025. The average cost of acquisition of shares by the promoters is Rs. 0.07, Rs. 2.50, and Rs. 10.22 per share.

Post-IPO, company’s current paid-up equity capital of Rs. 8.00 cr. (8000000 equity shares) will stand enhanced to Rs. 11.43 cr. (11429600 equity shares). Based on the upper band of the IPO pricing, the company is looking for a market cap of Rs. 116.58 cr.

Financial Performance

On the financial performance front, for the last three fiscals, the company has reported a total income/net profit of Rs. 41.39 cr. / Rs. 1.66 cr. (FY24), Rs. 49.32 cr. / Rs. 5.35 cr. (FY25), and Rs. 52.59 cr. / Rs. 5.64 cr. (FY26). It marked growth in its top and bottom lines for the reported periods. However, the PAT margins from FY25 onwards raise eyebrows and concern over its sustainability going forward as it is operating in a highly competitive and fragmented segment. Its debt-equity ratio of 3.20 as of March 31, 2026 raise alarm.

For the last three fiscals, the company has reported an average EPS of Rs. 6.10, and an average RoNW of 44.51%. The issue is priced at a P/BV of 4.73 based on its NAV of Rs. 21.58 per share as of March 31, 2026, but its post-IPO NAV data is missing from the offer documents.

If we attribute FY26 super earnings to its post-IPO fully diluted paid-up equity capital, then the asking price is at a P/E of 20.69, and based on FY25 earnings, the P/E stands at 21.79. The issue appears fully priced, based on its average earnings.

For the reported periods, the company has posted PAT margins of 4.00% (FY24), 10.85% (FY25), 10.74% (FY26), and RoCE margins of 14.96%, 22.70%, 19.09%, respectively, for referred periods.

All amounts in Indian Rupees crores

Period Ended Revenue Expense PAT Assets
2024 ₹41.39 ₹39.19 ₹1.66 ₹51.35
2025 ₹49.32 ₹41.89 ₹5.35 ₹63.90
2026 ₹52.59 ₹44.66 ₹5.64 ₹85.27
ABH Healthcare IPO

Dividend Policy

The company has not paid any dividend since incorporation. It will adopt a prudent dividend policy, based on its financial performance and future prospects.

Comparison with Listed Peers

As per the offer document, the company has shown Sangani Hospitals, Maitreya Medicare, and Asarfi Hospital as its listed peers. They are currently trading at a P/E of 24.1, NA, and 24 (as of August 21, 2026). However, they are not truly comparable on an apple-to-apple basis.

Company EPS PE Ratio RoNW % NAV Income
Sangani Hospitals Limited 2.17 24.52 16.20% 23.30 106.96 Cr.
Maitreya Medicare Limited (3.64) (34.11) (8.10)% 42.67 44.85 Cr.
Asarfi Hospital Limited 8.47 27.63 18.65% 49.62 173.50 Cr.

About Company

ABH Healthcare Ltd. (AHL) is engaged in the business of healthcare services. Its focus is on providing specialized tertiary medical care in Tier 3 cities, within the state of Punjab while seeking to strike a balance between providing quality healthcare services and affordability. WeIt operates hospital under the “Anil Baghi Hospital” brand and has a capacity of 150 beds. Acquired by the Company in 2022, the hospital was established in 1985 with 30 (thirty) beds and is driven by a vision to provide affordable, accessible, and quality healthcare services, delivered with compassion. Since its acquisition, it has consistently invested in the hospital, expanding bed capacity, increasing workforce, and introducing additional services and clinical specialties. As of the date of this Red Herring Prospectus, AHL had 150 (one hundred fifty) beds and offer 25 (twenty five) medical specialties in its hospital such as, cardiac sciences, neurology, minimally invasive spine and brain surgeries, gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, obstetrics and gynecology, adult and neonatal critical care, orthopedics and joint replacement, neuro-psychiatry and drug de-addiction, general & laparoscopic surgery, dentistry, physiotherapy, dermatology and lab investigations and radiology.

Its extensive 35+ years of experience in the healthcare industry in the region where it operates has helped the company to develop a strong understanding of the region’s market dynamics. It has an extensive network of empanelment which includes, over 30 (thirty) private and public health insurance companies and third-party administrators. In addition to private health insurance, it is also empaneled with all major government insurance schemes available in this region, including Ex-Servicemen Contributory Health Scheme (ECHS), Railways, Food Corporation of India (FCI), Bharat Sanchar Nigam Limited (BSNL), and Ayushman Bharat – Sarbat Sehat Bima Yojana (ABSSBY).

AHL’s hospital has also received various accreditations including, the accreditations from the National Accreditation Board for Hospitals and Healthcare Providers (“NABH”) in 2021. Further, in the Fiscal 2025 it has also been accredited with NABH Digital Standards, highlighting its adoption of cutting-edge digital technologies in healthcare. The company has adopted comprehensive information technology ecosystem aimed at transforming both the patient and clinical experience, as well as boosting the business and operational efficiency. Central to its strategy is the adoption of cutting-edge technologies, including digitalizing its patient experience through patient portal, website and widely-used messaging platforms.

The company has also implemented a state-of-the-art Computerized Physician Order Entry (CPOE) system and Electronic Health Record (EHR) platform, licensed from a third-party service provider. It has installed an inhouse Dell PowerEdge R660xs T40 Server for storage of data along with other data safety measures. Further, it has employed a professional to look after any kind of issues related to IT system. As of June 30, 2026, it had a team of over 309 staff (including professionals), including 37 doctors, 101 nurses and 171 other personnel. Its doctors are engaged on a payroll basis, on a full-time or parttime consultancy basis. The company also had up to 18 medical officers as at June 30, 2026.

Merchant Banker’s Track Record

This is 27th mandate from Fedex Securities in the last four fiscals (including the ongoing one). Out of last 10 listings, 2 listed at discount 1 at par, and the rest with premium ranging from 6.11% to 90% on the listing date.

Conclusion

AHL is engaged in the business of providing healthcare services in Tier-3 cities in the northern region. It has a capacity of 150 beds and empaneled with private and public health insurance companies. The company posted growth in its top and bottom lines, with affordable health related services. It is operating in a highly competitive and fragmented segment. Based on its recent financial data, the issue appears fully priced. Well-informed/cash surplus/risk seekers may park moderate funds for long term.

⚖️ Statutory Regulatory & Copyright Disclaimer

SEBI Compliance Note: ipoind.com is an independent financial analytics and primary market research portal provided solely for educational and informational purposes. We are NOT a SEBI-registered Investment Advisor or Research Analyst. Financial market investments, equity securities, and Initial Public Offerings (IPOs) carry inherent market risks.

Grey Market Premium (GMP) Notice: Figures regarding Grey Market Premium (GMP), Kostak rates, and subject-to-sauda deals reflect unofficial, unregulated over-the-counter market sentiment. These figures do not guarantee exchange listing prices or actual trading outcomes. Always evaluate official Draft Red Herring Prospectus (DRHP / RHP) documents filed with BSE/NSE and consult a certified financial advisor prior to executing financial bidding decisions.

© 2026 ipoind.com. All verified market intelligence, algorithmic layout structures, and curated analytics are protected.
Scroll to Top
⚡ IPOIND Directory
🔥 Live Tracking & Dashboards
⚡ Live GMP Today 📈 Live GMP & Sub Dashboard 📊 Day-Wise Subscription 📅 Upcoming IPO Pipeline
📋 Allotment, Quotas & Stories
🔍 Live Allotment Status 👥 Shareholder Quota Guide 📜 My 20 Allotments Record 📝 IPO Applying Strategy Guide
🧮 Interactive Financial Tools
🎯 Allotment Probability Calculator 📈 SIP Return Calculator 💵 Listing Gain Calculator
📚 Knowledge & Compliance Hub
💡 What is an IPO? 📑 Mainboard IPO Rules (SEBI) ⚖️ SME vs Mainboard Comparison 📂 DRHP Documents Hub 🏢 Unlisted Shares Hub
ℹ️ Company & Support
👤 About Our Platform 📩 Contact Support Desk
🤖
IPO Intelligence Brain v3.0
● Online • 50+ Financial Topics Synced
नमस्ते! मैं IPOIND Intelligence AI हूँ। 📈
मुझसे लाइव GMP, अलॉटमेंट प्रोबेबिलिटी, SEBI नियम, पैरेंट शेयरहोल्डर कोटा, या 20 वेरीफाइड IPOs (Bajaj Housing, Rajputana SME, Milky Mist, आदि) के केस स्टडी के बारे में कुछ भी विस्तार से पूछें!